AU Patent

AU2004234176B2 — Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts

Assigned to Globopharm Pharmazeutische Produktions und Handelsgesellschaft mbH · Expires 2010-05-13 · 16y expired

What this patent protects

The invention relates to a solid pharmaceutical preparation containing water-soluble salts of Levothyroxine and/or Liothyronine as active agent, wherein water activity of the pharmaceutical preparation measured at room temperature is set to values below 0.4, preferably 0.1 to 0.3…

USPTO Abstract

The invention relates to a solid pharmaceutical preparation containing water-soluble salts of Levothyroxine and/or Liothyronine as active agent, wherein water activity of the pharmaceutical preparation measured at room temperature is set to values below 0.4, preferably 0.1 to 0.3.

Drugs covered by this patent

Patent Metadata

Patent number
AU2004234176B2
Jurisdiction
AU
Classification
—
Expires
2010-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Globopharm Pharmazeutische Produktions und Handelsgesellschaft mbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.